Auris Medical (NASDAQ:EARS)

CAPS Rating: 1 out of 5

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

6 Outperform
12 Underperform
 

All-Star Players

2 Outperform
7 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top EARS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

shanelofgren (31.46)
Submitted July 28, 2016

This one is a bit tricky to value, so I will spend most of my time with a newsflow oriented pitch instead.But as a simple valuation, top down, you have cap of 142, with net cash most likely in the range of 25. So, platform and pipeline are currently… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

EARS VS S&P 500 (SPY)

EARS Summary

Recent Community Commentary

Read the most recent pitches from players about EARS.

Recs

0
Member Avatar TerryHogan (99.97) Submitted: 10/12/2018 1:32:17 AM : Underperform Start Price: $0.78 EARS Score: +37.41

I think this is an excellent space to be in, given baby boomers rock concert attendance. But this company has no revenues and not enough cash to keep the lights on for much longer. Dangerous betting against something with such a small market cap though, as a tiny amount of revenue could mean a huge pop percentage-wise. Same goes for an acquisition, and this thing is a rounding error for any big company.

Recs

0
Member Avatar KingMR012 (< 20) Submitted: 10/8/2018 6:24:12 PM : Outperform Start Price: $0.60 EARS Score: -16.38

Upcoming phase 3 clinical trial to be released as product for tinnitus and sudden hearing loss. This will be a great for people with inner ear disorders and complications.

Recs

0
Member Avatar superstar2 (99.57) Submitted: 8/18/2016 10:50:10 AM : Outperform Start Price: $2.21 EARS Score: -101.57

Good news for vulture buyers: This Switzerland-based company stated its TACTT2 trial with Keyzilen(TM) for acute inner ear tinnitus missed its primary efficacy endpoints.

Leaderboard

Find the members with the highest scoring picks in EARS.

Score Leader

srkenne264

srkenne264 (99.45) Score: +281.35

Thx for the calls

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
shake656 47.11 9/14/2016 Underperform 5Y $1.70 -72.87% +25.07% +97.94 0 Comment
risktech < 20 4/11/2018 Underperform 5Y $1.37 -66.34% +1.61% +67.95 0 Comment
cashsage 98.63 10/16/2018 Underperform 5Y $1.44 -67.97% -4.37% +63.61 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. gpierson128 97.85 10/9/2017 Underperform 5Y $0.93 -50.41% +5.14% +55.55 0 Comment
WSMOOT19 71.40 3/8/2017 Underperform 1Y $0.75 -38.51% +12.80% +51.30 0 Comment
FadeTheChalk 26.56 10/24/2017 Underperform 5Y $0.78 -40.49% +4.35% +44.84 0 Comment
TheSlightEdge 99.09 10/24/2018 Underperform 5Y $0.82 -43.42% -0.25% +43.17 0 Comment
TerryHogan 99.97 10/12/2018 Underperform 5Y $0.78 -40.68% -3.27% +37.41 1 Comment
mavericktrading 99.21 11/8/2018 Underperform 5Y $0.70 -34.06% -4.61% +29.45 0 Comment
PestAssassin0065 45.98 11/30/2018 Underperform 5Y $0.59 -21.16% -2.69% +18.47 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EARS.

Advertisement